About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Although these factors will affect Omron's free cash flow generation in fiscal 2024, we expect this to be temporary and the company's financial health to return to its normal state over the medium ...